Acceleron’s post-Reblozyl plan comes together

Acceleron’s post-Reblozyl plan comes together

Source: 
EP Vantage
snippet: 

Sotatercept’s win in pulmonary arterial hypertension positions Acceleron for a battle against the leaders in this crowded space.